Drug Shortage Report for DILAUDID HP
| Report ID | 12825 |
| Drug Identification Number | 00622133 |
| Brand name | DILAUDID HP |
| Common or Proper name | Hydromorphone |
| Company Name | PURDUE PHARMA |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10 x 5 mL ampoules |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-06-15 |
| Actual start date | 2017-06-15 |
| Estimated end date | 2017-12-31 |
| Actual end date | 2017-12-31 |
| Shortage status | Resolved |
| Updated date | 2020-03-23 |
| Company comments | Inventory Constraints |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-03-23 | French | Compare |
| v4 | 2020-03-23 | English | Compare |
| v3 | 2017-06-16 | English | Compare |
| v2 | 2017-06-15 | French | Compare |
| v1 | 2017-06-15 | English | Compare |
Showing 1 to 5 of 5